Belite Bio GAAP EPS of -0.26

BLTE Stock  USD 66.70  0.15  0.22%   
About 62% of Belite Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Belite Bio ADR suggests that many traders are alarmed. The current market sentiment, together with Belite Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Belite Bio ADR stock news signals to limit their universe of possible portfolio assets.
  
Belite Bio press release Q2 GAAP EPS of -0.26.As of June 30, 2023, the Company had 57.4 million in cash.For the three months ended June 30, 2023, research and...

Read at seekingalpha.com
seekingalpha News
  

Belite Bio Fundamental Analysis

We analyze Belite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Belite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Belite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Belite Bio is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Belite Bio ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Belite Bio stock to make a market-neutral strategy. Peer analysis of Belite Bio could also be used in its relative valuation, which is a method of valuing Belite Bio by comparing valuation metrics with similar companies.

Peers

Belite Bio Related Equities

MOLNMolecular Partners   6.05   
0%
54.0%
ANABAnaptysBio   1.61   
0%
14.0%
VIGLVigil Neuroscience   1.06   
0%
9.0%
AVTEAerovate Therapeutics   0.80   
0%
7.0%
CNTACentessa Pharmaceuticals   0.55   
0%
4.0%
GLTOGalecto   0.29   
2.0%
0%
IKNAIkena Oncology   0.75   
6.0%
0%
IMRXImmuneering Corp   1.20   
10.0%
0%
LRMRLarimar Therapeutics   2.08   
18.0%
0%
MLYSMineralys Therapeutics,   2.27   
20.0%
0%
CELCCelcuity LLC   2.85   
25.0%
0%
ANEBAnebulo Pharmaceuticals   2.86   
25.0%
0%
GLUEMonte Rosa   3.04   
27.0%
0%
ANTXAN2 Therapeutics   3.47   
31.0%
0%
PMVPPmv Pharmaceuticals   3.48   
31.0%
0%
TRDAEntrada Therapeutics   4.02   
36.0%
0%
ALGSAligos Therapeutics   5.59   
50.0%
0%
ADAGAdagene   6.59   
59.0%
0%
ACRVAcrivon Therapeutics,   11.11   
100.0%
0%

Complementary Tools for Belite Stock analysis

When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum